# Combination Therapy With Oral 9-Nitrocamptothecin & Oral Etoposide

> **NCT00006047** · PHASE1 · COMPLETED · sponsor: **H. Lee Moffitt Cancer Center and Research Institute** · enrollment: 44 (actual)

## Conditions studied

- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **DRUG:** Oral Etoposide
- **DRUG:** Oral 9-Nitrocamptothecin

## Key facts

- **NCT ID:** NCT00006047
- **Lead sponsor:** H. Lee Moffitt Cancer Center and Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-06
- **Primary completion:** 2003-02
- **Final completion:** 2003-02
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2012-09-26

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00006047

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00006047, "Combination Therapy With Oral 9-Nitrocamptothecin & Oral Etoposide". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00006047. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*